HDAC8 and Cornelia de Lange syndrome: <h4>Aim</h4>Human histone deacetylase 8 (KDAC8) is a well-recognized pharmaceutical target in Cornelia de Lange syndrome and different types of cancer, particularly childhood neuroblastoma.